LivaNova PLC (LIVN) Insider Trading

Last 12 months

Insiders sold $1.05M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Francesco Bianchi sold $273k on Sep 10, 44% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2021.

Net open-market

−$1.05M

0 buys · 7 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

Nov 2021

Nov 10, 2021

Get an email when LIVN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 10	Francesco Bianchi Director	SoldNo plan	3,500	$78.01	$273k	44%	Form 4
Sep 4	Brooke Story Director	SoldNo plan	2,300	$81.42	$187k	23%	Form 4
Aug 31	Francesco Bianchi Director	SoldNo plan	1,650	$79.72	$132k	17%	Form 4
Aug 11	Ahmet Tezel Chief Innovation Officer	SoldNo plan	2,675	$77.74	$208k	31%	Form 4
Jun 15	Francesco Bianchi Director	SoldNo plan	1,200	$80.19	$96k	11%	Form 4
May 26	Francesco Bianchi Director	SoldNo plan	1,800	$75.75	$136k	20%	Form 4
Nov 18, 2025	Brooke Story Director	SoldNo plan	250	$53.94	$13k	3.9%	Form 4
Aug 25, 2025	Francesco Bianchi Director	SoldNo plan	1,500	$56.50	$85k	14%	Form 4
Dec 11, 2024	Francesco Bianchi Director	SoldNo plan	1,250	$50.99	$64k	14%	Form 4

Sep 10No plan
Francesco Bianchi
Director · sold 3,500 at $78.01
$273k
44% of stake
Sep 4No plan
Brooke Story
Director · sold 2,300 at $81.42
$187k
23% of stake
Aug 31No plan
Francesco Bianchi
Director · sold 1,650 at $79.72
$132k
17% of stake
Aug 11No plan
Ahmet Tezel
Chief Innovation Officer · sold 2,675 at $77.74
$208k
31% of stake
Jun 15No plan
Francesco Bianchi
Director · sold 1,200 at $80.19
$96k
11% of stake
May 26No plan
Francesco Bianchi
Director · sold 1,800 at $75.75
$136k
20% of stake
Nov 18, 2025No plan
Brooke Story
Director · sold 250 at $53.94
$13k
3.9% of stake
Aug 25, 2025No plan
Francesco Bianchi
Director · sold 1,500 at $56.50
$85k
14% of stake
Dec 11, 2024No plan
Francesco Bianchi
Director · sold 1,250 at $50.99
$64k
14% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LIVN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Electromedical & Electrotherapeutic Apparatus

CNMDCONMED Corporation

MASIMasimo Corporation

ITGRInteger Holdings Corporation

TMDXTransMedics Group Inc.

INMDInMode Ltd.

AXGNAxogen Inc.

PENPenumbra Inc.

MMSIMerit Medical Systems, Inc.

Spot a number that looks wrong? Check it in LIVN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LIVN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.